Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: Trouble at the borders

International Review of Psychiatry

Volumn 17, Issue 1, 2005, Pages 9-19

  Kempf, L ^a   Hussain, N ^a   Potash, James B ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; RISPERIDONE; VALPROIC ACID;

BRAIN RADIOGRAPHY; CLINICAL FEATURE; CLINICAL TRIAL; DELUSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; GENE EXPRESSION; GENETIC LINKAGE; GENETICS; HUMAN; MOOD DISORDER; NEUROBIOLOGY; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RELIABILITY; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

DIAGNOSIS, DIFFERENTIAL; FACTOR ANALYSIS, STATISTICAL; GENE EXPRESSION; HUMANS; LINKAGE (GENETICS); MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 17844371088     PISSN: 09540261     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540260500064959     Document Type: Review

References (109)

1. Addington, A. M., Gornick, M., Sporn, A. L., Gogtay, N., Greenstein, D., Lenane, M., et al. (2004). Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biological Psychiatry, 55, 976-980.
2. Ahlfors, U. G., Baastrup, P. C., Dencker, S. J., Elgen, K., Lingjaerde, O., Pedersen, V., et al. (1981). Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatrica Scandinavica, 64, 226-237.
3. Badner, J. A., & Gershon, E. S. (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry, 7, 405-411.
4. Basan, A., & Leucht, S. (2004). Valproate for schizophrenia. Cochrane Database System Rev, CD004028.
5. Berrettini, W. H. (2000). Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biological Psychiatry, 48, 531-538.
6. Berrettini, W. H., Ferraro, T. N., Goldin, L. R., Weeks, D. E., Detera-Wadleigh, S., Nurnberger, J. I. J., et al. (1994). Chromosome 18 DNA markers and manic-depressive illness: Evidence for a susceptibility gene. Proceedings of the National Academy of Science USA, 91, 5918-5921.
7. Black, D. W., & Nasrallah, A. (1989). Hallucinations and delusions in 1715 patients with unipolar and bipolar affective disorders. Psychopathology, 22, 28-34.
8. Blouin, J. L., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S., Nestadt, G., et al. (1998). Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nature Genetics, 20, 70-73.
9. Brzustowicz, L. M., Honer, W. G., Chow, E. W., Little, D., Hogan, J., Hodgkinson, K., et al. (1999). Linkage of familial schizophrenia to chromosome 13q32. American Journal of Human Genetics, 65, 1096-1103.
10. Burch Jr., E. A., Anton, R. F., & Carson, W. H. (1994). Mood congruent and incongruent psychotic depressions: Are they the same? Journal of Affective Disorders, 31, 275-280.
11. Cardno, A. G., Rijsdijk, F. V., Sham, P. C., Murray, R. M., & McGuffin, P. (2002). A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry, 159, 539-545.
12. Carpenter, W. T. J., Strauss, J. S., & Muleh, S. (1973). Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Archives in General Psychiatry, 28, 847-852.
13. Chen, Y. S., Akula, N., Detera-Wadleigh, S. D., Schulze, T. G., Thomas, J., Potash, J. B., et al. (2004). Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Molecular Psychiatry, 9, 87-92.
14. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Science USA, 99, 13675-13680.
15. Citrome, L., Jaffe, A., Levine, J., & Allingham, B. (2002). Use of mood stabilizers among patients with schizophrenia, 1994-2001. Psychiatric Services, 53, 1212.
16. Delisi, L. E., Goldin, L. R., Maxwell, M. E., Kazuba, D. M., & Gershon, E. S. (1987). Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Archives in General Psychiatry, 44, 891-896.
17. Detera-Wadleigh, S. D., Badner, J. A., Berrettini, W. H., Yoshikawa, T., Goldin, L. R., Turner, G., et al. (1999). A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proceedings of the National Academy of Science USA, 96, 5604-5609.
18. Drevets, W. C., Price, J. L., Simpson Jr., J. R., Todd, R. D., Reich, T., Vannier, M., et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824-827.
19. Elkis, H., Friedman, L., Wise, A., & Meltzer, H. Y. (1995). Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. Archives in General Psychiatry, 52, 735-746.
20. Erlenmeyer-Kimling, L., Adamo, U. H., Rock, D., Roberts, S. A., Bassett, A. S., Squires-Wheeler, E., et al. (1997). The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up. Archives in General Psychiatry, 54, 1096-1102.
21. Ertugrul, A., & Meltzer, H. Y. (2003). Antipsychotic drugs in bipolar disorder. International Journal of Neuropsychopharmacology., 6, 277-284.
22. Esparon, J., Kolloori, J., Naylor, G. J., Mcharg, A. M., Smith, A. H., & Hopwood, S. E. (1986). Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. British Journal of Psychiatry, 148, 723-725.
23. Faraone, S. V., Blehar, M., Pepple, J., Moldin, S. O., Norton, J., Nurnberger, J. I., et al. (1996). Diagnostic accuracy and confusability analyses: An application to the Diagnostic Interview for Genetic Studies. Psychological Medicine, 26, 401-410.
24. Faraone, S. V., Matise, T., Svrakic, D., Pepple, J., Malaspina, D., Suarez, B., et al. (1998). Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium. American Journal of Medical Genetics, 81, 290-295.
25. Farmer, A. E., McGuffin, P., & Gottesman, I. I. (1987). Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition. Archives in General Psychiatry, 44, 634-641.
26. Fennig, S., Bromet, E. J., Karant, M. T., Ram, R., & Jandorf, L. (1996). Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder. Journal of Affective Disorders, 37, 23-29.
27. Foroud, T., Castelluccio, P. F., Koller, D. L., Edenberg, H. J., Miller, M., Bowman, E., et al. (2000). Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. American Journal of Medical Genetics, 96, 18-23.
28. Forrester, A., Owens, D. G., & Johnstone, E. C. (2001). Diagnostic stability in subjects with multiple admissions for psychotic illness. Psychological Medicine, 31, 151-158.
29. Gershon, E. S., Delisi, L. E., Hamovit, J., Nurnberger, J. I. J., Maxwell, M. E., Schreiber, J., et al. (1988). A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Archives in General Psychiatry, 45, 328-336.
30. Gershon, E. S., Hamovit, J., Guroff, J. J., Dibble, E., Leckman, J. F., Sceery, W., et al. (1982). A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Archives in General Psychiatry, 39, 1157-1167.
31. Gill, M., Vallada, H., Collier, D., Sham, P., Holmans, P., Murray, R., et al. (1996). A combined analysis of D22S278 marker alleles in affected sib-pairs: Support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative linkage Group (Chromosome 22). American Journal of Medical Genetics, 67, 40-45.
32. Goodwin, F. K., & Jamison, K. R. (1990). Manic-Depressive Illness. New York: Oxford University Press.
33. Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D., Dwivedi, Y., Grayson, D. R., et al. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. A postmortem brain study. Archives in General Psychiatry, 57, 1061-1069.
34. Harrison, P. J. (2002). The neuropathology of primary mood disorder. Brain, 125, 1428-1449.
35. Harrow, M., Grossman, L. S., Herbener, E. S., & Davies, E. W. (2000). Ten-year outcome: Patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. British Journal of Psychiatry, 177, 421-426.
36. Hattori, E., Liu, C., Badner, J. A., Bonner, T. I., Christian, S. L., Maheshwari, M., et al. (2003). Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. American Journal of Human Genetics, 72, 1131-1140.
37. Heila, H., Isometsa, E. T., Henriksson, M. M., Heikkinen, M. E., Marttunen, M. J., & Lonnqvist, J. K. (1997). Suicide and schizophrenia: A nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. American Journal of Psychiatry, 154, 1235-1242.
38. Hirayasu, Y., Shenton, M. E., Salisbury, D. F., Dickey, C. C., Fischer, I. A., Mazzoni, P., et al. (1998). Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. American Journal of Psychiatry, 155, 1384-1391.
39. Hirayasu, Y., Shenton, M. E., Salisbury, D. F., Kwon, J. S., Wible, C. G., Fischer, I. A., et al. (1999). Subgenual cingulate cortex volume in first-episode psychosis. American Journal of Psychiatry, 156, 1091-1093.
40. Hodgkinson, C. A., Goldman, D., Jaeger, J., Persaud, S., Kane, J. M., Lipsky, R. H., et al. (2004). Disrupted in Schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. American Journal of Human Genetics, 75, 862-872.
41. Jablensky, A., Hugler, H., Von, C. M., & Kalinov, K. (1993). Kraepelin revisited: A reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908. Psychological Medicine, 23, 843-858.
42. Johnson, D. A. (1988). The significance of depression in the prediction of relapse in chronic schizophrenia. British Journal of Psychiatry, 152, 320-323.
43. Jorgensen, P., & Mortensen, P. B. (1988). Admission pattern and diagnostic stability of patients with functional psychoses in Denmark during a two-year observation period. Acta Psychiatrica Scandinavica., 78, 361-365.
44. Kasai, K., Shenton, M. E., Salisbury, D. F., Onitsuka, T., Toner, S. K., Yurgelun-Todd, D., et al. (2003). Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Archives in General Psychiatry, 60, 1069-1077.
45. Kasanin, J. (1933). The acute schizoaffective psychoses. American Journal of Psychiatry, 90, 97-126.
46. Kelsoe, J. R., Spence, M. A., Loetscher, E., Foguet, M., Sadovnick, A. D., Remick, R. A., et al. (2001). A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proceedings of the National Academy of Science USA, 98, 585-590.
47. Kendell, R. E. (1974). The stability of psychiatric diagnosis. British Journal of Psychiatry, 124, 352-356.
48. Kendler, K. S. (1991). Mood-incongruent psychotic affective illness. A historical and empirical review. Archives in General Psychiatry, 48, 362-369.
49. Kendler, K. S., Gruenberg, A. M., & Tsuang, M. T. (1985). Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Archives in General Psychiatry, 42, 770-779.
50. Kendler, K. S., Gruenberg, A. M., & Tsuang, M. T. (1986). A DSM-III family study of the non-schizophrenic psychotic disorders. American Journal of Psychiatry, 143, 1098-1105.
51. Kendler, K. S., Karkowski-Shuman, L., O'Neill, F. A., Straub, R. E., Maclean, C. J., & Walsh, D. (1997). Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: Evidence for possible etiologic heterogeneity. American Journal of Psychiatry, 154, 191-198.
52. Kendler, K. S., McGuire, M., Gruenberg, A. M., O'Hare, A., Spellman, M., & Walsh, D. (1993a). The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives in General Psychiatry, 50, 527-540.
53. Kendler, K. S., McGuire, M., Gruenberg, A. M., O'Hare, A., Spellman, M., & Walsh, D. (1993b). The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Archives in General Psychiatry, 50, 952-960.
54. Koh, P. O., Undie, A. S., Kabbani, N., Levenson, R., Goldman-Rakic, P. S., & Lidow, M. S. (2003). Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proceedings of the National Academy of Science USA, 100, 313-317.
55. Korostishevsky, M., Kaganovich, M., Cholostoy, A., Ashkenazi, M., Ratner, Y., Dahary, D., et al. (2004). Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biological Psychiatry, 56, 169-176.
56. Kraepelin, E. (1899). Manic-depressive insanity and paranoia.
57. Lehmann, H. E., & Hanrahan, G. E. (1954). Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states. American Medical Association, Archives in Neurology & Psychiatry, 71, 227-237.
58. Leucht, S., Kissling, W., & McGrath, J. (2004). Lithium for schizophrenia revisited: A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry, 65, 177-186.
59. Leucht, S., McGrath, J., White, P., & Kissling, W. (2002). Carbamazepine for schizophrenia and schizoaffective psychoses. Cochrane Database System Rev, CD001258.
60. Lin, M. W., Sham, P., Hwu, H. G., Collier, D., Murray, R., & Powell, J. F. (1997). Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Human Genetics, 99, 417-420.
61. Littlejohn, R., Leslie, F., & Cookson, J. (1994). Depot antipsychotics in the prophylaxis of bipolar affective disorder. British Journal of Psychiatry, 165, 827-829.
62. Maier, W., Lichtermann, D., Minges, J., Hallmayer, J., Heun, R., Benkert, Ë., & Levinson, D. F. (1993). Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Archives in General Psychiatry, 50, 871-883.
63. Maj, M., Pirozzi, R., Formicola, A. M., Bartoli, L., & Bucci, P. (2000). Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: Preliminary data. Journal of Affective Disorders, 57, 95-98.
64. Marneros, A., Deister, A., & Rohde, A. (1991). Stability of diagnoses in affective, schizoaffective and schizophrenic disorders. Cross-sectional versus longitudinal diagnosis. European Archives in Psychiatry & Clinical Neuroscience, 241, 187-192.
65. Maziade, M., Roy, M. A., Martinez, M., Cliche, D., Fournier, J. P., Garneau, Y., et al. (1995). Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: Continuity and discontinuity between the major psychoses. American Journal of Psychiatry, 152, 1458-1463.
66. McDonald, C., Bullmore, E. T., Sham, P. C., Chitnis, X., Wickham, H., Bramon, E., et al. (2004). Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Archives in General Psychiatry, 61, 974-984.
67. McHugh, P. R., & Slavney, P. R. (1998). The Perspectives of Psychiatry (Second Edition). Baltimore: Johns Hopkins University Press.
68. McIntosh, A. M., Forrester, A., Lawrie, S. M., Byrne, M., Harper, A., Kestelman, J. N., et al. (2001). A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology. Psychological Medicine, 31, 159-171.
69. Nothen, M. M., Cichon, S., Rohleder, H., Hemmer, S., Franzek, E., Fritze, J., et al. (1999). Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Molecular Psychiatry, 4, 76-84.
70. Omahony, E., Corvin, A., O'Connell, R., Comerford, C., Larsen, B., Jones, R., et al. (2002). Sibling pairs with affective disorders: Resemblance of demographic and clinical features. Psychological Medicine, 32, 55-61.
71. Ozeki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., et al. (2003). Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proceedings of the National Academy of Science USA, 100, 289-294.
72. Pearlson, G. D., Wong, D. F., Tune, L. E., Ross, C. A., Chase, G. A., Links, J. M., et al. (1995). In vivo D2 dopamine receptor density in psychotic and non-psychotic patients with bipolar disorder. Archives in General Psychiatry, 52, 471-477.
73. Plum, F. (1972). Prospects for research on schizophrenia. 3. Neurophysiology. Neuropathological findings. Neuroscience Research Programs Bulletin, 10, 384-388.
74. Pope Jr., H. G., & Lipinski, J. F., Jr. (1978). Diagnosis in schizophrenia and manic-depressive illness: A reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Archives in General Psychiatry, 35, 811-828.
75. Potash, J. B., Chiu, Y. F., MacKinnon, D. F., Miller, E. B., Simpson, S. G., McMahon, F. J., et al. (2003a). Familial aggregation of psychotic symptoms in a replication set of 69 bipolar disorder pedigrees. American Journal of Medical Genetics, 160, 680-686.
76. Potash, J. B., Zandi, P. P., Willour, V. L., Lan, T. H., Huo, Y., Avramopoulos, D., et al. (2003b). Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. American Journal of Psychiatry, 160, 680-686.
77. Potash, J. B., Willour, V. L., Chiu, Y.-F., Simpson, S. G., MacKinnon, D. F., Pearlson, G. D., et al. (2001). The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. American Journal of Psychiatry, 158, 1258-1264.
78. Pulver, A. E., Mulle, J., Nestadt, G., Swartz, K. L., Blouin, J.-L., Dombroski, B., et al. (2000). Genetic heterogeneity in schizophrenia: Stratification of genome scan data using co-segregating related phenotypes. Molecular Psychiatry, 5, 650-653.
79. Ratakonda, S., Gorman, J. M., Yale, S. A., & Amador, X. F. (1998). Characterization of psychotic conditions. Use of the domains of psychopathology model. Archives in General Psychiatry, 55, 75-81.
80. Rounsaville, B. J., Alarcon, R. D., Andrews, G., Jackson, J. S., Kendell, R. E., & Kendler, K. (2002). Basic nomenclature issues for DSM-V. 1-29.
81. Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002). Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety. American Journal of Psychiatry, 159, 1146-1154.
82. Salokangas, R. K., Cannon, T., Van, E. T., Ilonen, T., Taiminen, T., Karlsson, H., et al. (2002). Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Results of the schizophrenia and affective psychoses (SAP) project. British Journal of Psychiatry, 43(Suppl), s58-s65.
83. Schizophrenia Collaborative Linkage Group For Chromosome 22. (1998). A transmission disequilibrium and linkage analysis of D22S278 marker alleles in 574 families: Further support for a susceptibility locus for schizophrenia at 22q12. Schizophrenia Research, 32, 115-121.
84. Schneider, K., & (transl. M. W. Hamilton) (1959). Clinical Psychopathology. New York: Grune and Stratton.
85. Schumacher, J., Jamra, R. A., Freudenberg, J., Becker, T., Ohlraun, S., Otte, A. C., et al. (2004). Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Molecular Psychiatry, 9, 203-207.
86. Schurhoff, F., Szoke, A., Meary, A., Bellivier, F., Rouillon, F., Pauls, D., et al. (2003). Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. American Journal of Psychiatry, 160, 1313-1319.
87. Schwab, S. G., Hallmayer, J., Albus, M., Lerer, B., Eckstein, G. N., Borrmann, M., et al. (2000). A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: Support for loci on chromosome 10p and 6. Molecular Psychiatry, 5, 638-649.
88. Schwab, S. G., Hallmayer, J., Lerer, B., Albus, M., Borrmann, M., Honig, S., et al. (1998). Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. American Journal of Human Genetics, 63, 1139-1152.
89. Schwartz, J. E., Fennig, S., Tanenberg-Karant, M., Carlson, G., Craig, T., Galambos, N., et al. (2000). Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Archives in General Psychiatry, 57, 593-600.
90. Sham, P. C., Castle, D. J., Wessely, S., Farmer, A. E., & Murray, R. M. (1996). Further exploration of a latent class typology of schizophrenia. Schizophrenia Research, 20, 105-115.
91. Sham, P. C., Maclean, C. J., & Kendler, K. S. (1994). A typological model of schizophrenia based on age at onset, sex and familial morbidity. Acta Psychiatrica Scandinavica, 89, 135-141.
92. Siris, S. G. (2000). Depression in schizophrenia: Perspective in the era of 'Atypical' anti-psychotic agents. American Journal of Psychiatry, 157, 1379-1389.
93. Spiker, D. G., Weiss, J. C., Dealy, R, S., Griffin, S. J., Hanin, I., Neil, J. F., et al. (1985). The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142, 430-436.
94. Stine, O. C., Xu, J., Koskela, R., McMahon, F. J., Gschwend, M., Friddle, C., et al. (1995). Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. American Journal of Human Genetics, 57, 1384-1394.
95. Strakowski, S. M., Delbello, M. P., Sax, K. W., Zimmerman, M. E., Shear, P. K., Hawkins, J. M., et al. (1999). Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Archives in General Psychiatry, 56, 254-260.
96. Straub, R. E., Maclean, C. J., Martin, R. B., Ma, Y., Myakishev, M. V., Harris-Kerr, C., et al. (1998). A schizophrenia locus may be located in region 10p15-p11. American Journal of Medical Genetics, 81, 296-301.
97. Suppes, T., Webb, A., Paul, B., Carmody, T., Kraemer, H., & Rush, A. J. (1999). Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American Journal of Psychiatry, 156, 1164-1169.
98. Tohen, M., Chengappa, K. N., Suppes, T., Baker, R. W., Zarate, C. A., Bowden, C. L., et al. (2004). Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser versus mood stabiliser alone. British Journal of Psychiatry, 184, 337-345.
99. Tohen, M., Tsuang, M. T., & Goodwin, D. C. (1992). Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. American Journal of Psychiatry, 149, 1580-1584.
100. Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, L, Tueting, P., et al. (2002). An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proceedings of the National Academy of Science USA, 99, 17095-17100.
101. Tsuang, M. T., Woolson, R. F., Winokur, G., & Crowe, R. R. (1981). Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. Archives in General Psychiatry, 38, 535-539.
102. Vaillant, G. E. (1964). Prospective prediction of schizophrenic remission. Archives in General Psychiatry, 11, 509-518.
103. Van, O. J., Gilvarry, C., Bale, R., Van, H. E., Tattan, T., White, I., et al. (1999). A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine, 29, 595-606.
104. Vawter, M. P., Thatcher, L., Usen, N., Hyde, T. M., Kleinman, J. E., & Freed, W. J. (2002). Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Molecular Psychiatry, 7, 571-578.
105. Wang, X., He, G., Gu, N., Yang, J., Tang, J., Chen, Q., et al. (2004). Association of G72/G30 with schizophrenia in the Chinese population. Biochemistry & Biophysics Research Communications, 319, 1281-1286.
106. White, E., Cheung, P., & Silverstone, T. (1993). Depot antipsychotics in bipolar affective disorder. International Clinical Psychopharmacology, 8, 119-122.
107. Whitehead, C., Moss, S., Cardno, A., & Lewis, G. (2003). Antidepressants for the treatment of depression in people with schizophrenia: A systematic review. Psychological Medicine, 33, 589-599.
108. Zarate Jr, C. A., (2000). Anti-psychotic drug side effect issues in bipolar manic patients. Journal of Clinical Psychiatry, 6J(Suppl. 8), 52-61 and discussion 62-63.
109. Zarate Jr, C. A., & Tohen, M. (2004). Double-blind comparison of the continued use of anti-psychotic treatment versus its discontinuation in remitted manic patients. American Journal of Psychiatry, 161, 169-171.